Primary Care Clinics in Huslia, AK Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Edgar Nollner Helath Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 90 Main Street, Huslia, AK 99746 Phone: 907-829-2281 Fax: 907-829-2203 |
News Archive
Study highlights cigarette smoking and risk perceptions during the COVID-19 pandemic
Last year, people who smoked had a variety of responses to the COVID-19 pandemic, with some increasing their smoking to help them cope and others quitting to potentially lessen their vulnerability to COVID-19.
Safety tips to avoid cooking accidents on Thanksgiving Day
Aficionados agree that deep-frying a turkey is the best way to prepare the most flavorful and moist version of the traditional centerpiece of the Thanksgiving meal. Serafino Alfe was deep-frying turkeys for an annual fundraiser dinner recently and ended up at the Loyola Burn unit with third-degree burns - the worst - on his leg.
WVU researcher investigates how nursing homes can best meet obese residents' healthcare needs
About 30 percent of nursing home residents are obese. That can complicate their care. The facility may need to buy them special wheelchairs or motorized lifts. Nursing aides may struggle to help them shower. And doctors may grapple with how-or even whether-to restrict their diets.
Duke University physicists develop technique to inject material into cells through sharp fluid jets
Duke University physicists have developed a way to produce sharp fluid jets with enough precision that they can inject material into a single, living cell. The technique promises a way to deliver drugs to cells one at a time, which is likely to be very valuable for research involving stem cells and other cellular-level studies. The research appears in the current issue of the APS journal Physical Review Letters.
Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.
› Verified 2 days ago